Two studies investigated the improvement of three different CKD progression models [33],[40], after adding biomarkers to traditional risk factors (serum bicarbonate and phosphate in one case [33], and Troponin T plus brain natriuretic peptide in the two other cases) [40]. This evidence concerns the gene NPPB and chronic kidney disease.